WO2008081928A1 - ピラゾロピリミジン化合物 - Google Patents
ピラゾロピリミジン化合物 Download PDFInfo
- Publication number
- WO2008081928A1 WO2008081928A1 PCT/JP2007/075278 JP2007075278W WO2008081928A1 WO 2008081928 A1 WO2008081928 A1 WO 2008081928A1 JP 2007075278 W JP2007075278 W JP 2007075278W WO 2008081928 A1 WO2008081928 A1 WO 2008081928A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyrazolopyrimidine compound
- disclosed
- pyrazolopyrimidine
- arthritides
- syk
- Prior art date
Links
- -1 Pyrazolopyrimidine compound Chemical class 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/521,518 US20100298557A1 (en) | 2006-12-28 | 2007-12-28 | Pyrazolopyrimidine compound |
KR1020097013434A KR20090103897A (ko) | 2006-12-28 | 2007-12-28 | 피라졸로피리미딘 화합물 |
JP2008552181A JPWO2008081928A1 (ja) | 2006-12-28 | 2007-12-28 | ピラゾロピリミジン化合物 |
EP07860481A EP2123654A4 (en) | 2006-12-28 | 2007-12-28 | pyrazolopyrimidine compound |
CA002673965A CA2673965A1 (en) | 2006-12-28 | 2007-12-28 | Pyrazolopyrimidine compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006353781 | 2006-12-28 | ||
JP2006-353781 | 2006-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008081928A1 true WO2008081928A1 (ja) | 2008-07-10 |
Family
ID=39588608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/075278 WO2008081928A1 (ja) | 2006-12-28 | 2007-12-28 | ピラゾロピリミジン化合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100298557A1 (ja) |
EP (1) | EP2123654A4 (ja) |
JP (1) | JPWO2008081928A1 (ja) |
KR (1) | KR20090103897A (ja) |
CN (1) | CN101611035A (ja) |
CA (1) | CA2673965A1 (ja) |
RU (1) | RU2009128982A (ja) |
WO (1) | WO2008081928A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009026107A1 (en) * | 2007-08-17 | 2009-02-26 | Portola Pharmaceuticals, Inc. | Protein kinase inhibitors |
WO2009032703A1 (en) * | 2007-08-28 | 2009-03-12 | Irm Llc | 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
WO2012057262A1 (ja) * | 2010-10-28 | 2012-05-03 | 日本新薬株式会社 | ピリジン誘導体及び医薬 |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
US8273754B2 (en) | 2008-12-30 | 2012-09-25 | Arqule, Inc. | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds |
US8343961B2 (en) | 2009-03-31 | 2013-01-01 | Arqule, Inc. | Substituted heterocyclic compounds |
US8372858B2 (en) | 2006-12-08 | 2013-02-12 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
JP2015529232A (ja) * | 2012-09-20 | 2015-10-05 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換ピロロピリミジニルアミノ−ベンゾチアゾロン |
US10913744B2 (en) | 2015-02-13 | 2021-02-09 | Dana-Farber Cancer Institute, Inc. | LRRK2 inhibitors and methods of making and using the same |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
DK2300013T3 (en) | 2008-05-21 | 2017-12-04 | Ariad Pharma Inc | PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS |
EP2365809B8 (en) | 2008-11-12 | 2018-10-10 | Ariad Pharmaceuticals, Inc. | Pyrazinopyrazines and derivatives as kinase inhibitors |
SI2516434T1 (sl) * | 2009-12-23 | 2015-10-30 | Takeda Pharmaceutical Company Limited | Zliti heteroaromatski pirolidinoni kot inhibitorji SYK |
JP2014501705A (ja) * | 2010-11-01 | 2014-01-23 | ポートラ ファーマシューティカルズ, インコーポレイテッド | Syk調節剤としてのベンズアミドおよびニコチンアミド |
TWI606049B (zh) * | 2011-04-21 | 2017-11-21 | 原真股份有限公司 | 新穎激酶抑制劑 |
AU2012250517B2 (en) | 2011-05-04 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
US9056873B2 (en) | 2011-06-22 | 2015-06-16 | Takeda Pharmaceutical Company Limited | Substituted 6-aza-isoindolin-1-one derivatives |
AU2013204563B2 (en) | 2012-05-05 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
US9637491B2 (en) | 2012-10-19 | 2017-05-02 | Origenis Gmbh | Pyrazolo[4,3-D]pyrimidines as kinase inhibitors |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
WO2015021149A1 (en) * | 2013-08-06 | 2015-02-12 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Inhibitors of ack1/tnk2 tyrosine kinase |
EP3142652B1 (en) | 2014-05-14 | 2021-08-25 | The Regents of the University of Colorado, a body corporate | Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof |
CN107406452B (zh) * | 2015-01-23 | 2019-07-23 | 葛兰素史密斯克莱知识产权发展有限公司 | 吡唑并[3,4-d]嘧啶衍生物及其治疗利什曼病的用途 |
CN107383014B (zh) * | 2017-06-21 | 2019-04-30 | 南方医科大学 | 一种1H-吡唑并[3,4-d]嘧啶类化合物及其制备方法和应用 |
EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
LT3966206T (lt) | 2019-05-10 | 2023-11-10 | Deciphera Pharmaceuticals, Llc | Heteroarilaminopirimidino amido autofagijos inhibitoriai ir jų naudojimo būdai |
EP3983081A1 (en) | 2019-06-17 | 2022-04-20 | Deciphera Pharmaceuticals, LLC | Aminopyrimidine amide autophagy inhibitors and methods of use thereof |
CN116023380B (zh) * | 2021-10-26 | 2024-01-23 | 沈阳药科大学 | 一类吡唑并嘧啶衍生物及制备方法和应用 |
CN115368366A (zh) * | 2022-08-02 | 2022-11-22 | 江苏省中医药研究院 | 嘧啶并吡唑类化合物及其应用 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4899194A (ja) | 1972-03-03 | 1973-12-15 | ||
WO2000075113A1 (fr) | 1999-06-09 | 2000-12-14 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives carboxamide heterocycliques |
JP2001501216A (ja) * | 1996-10-02 | 2001-01-30 | ノバルティス アクチエンゲゼルシャフト | ピリミジン誘導体およびその製造法 |
WO2001009134A1 (en) | 1999-07-30 | 2001-02-08 | Novartis Ag | Purine derivatives inhibitors of tyrosine protein kinase syk |
WO2001083485A1 (en) | 2000-04-28 | 2001-11-08 | Bayer Aktiengesellschaft | Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
WO2003057695A1 (en) | 2001-12-21 | 2003-07-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,6 naphthyridines useful as inhibitors of syk kinase |
WO2003063794A2 (en) | 2002-02-01 | 2003-08-07 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and their uses |
JP2004203748A (ja) | 2002-12-24 | 2004-07-22 | Kissei Pharmaceut Co Ltd | 新規なイミダゾ[1,2−c]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途 |
WO2005028480A2 (en) | 2003-09-03 | 2005-03-31 | Neurogen Corporation | 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
WO2005080393A1 (en) * | 2004-02-14 | 2005-09-01 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
WO2005085249A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Fused derivatives of pyrazole |
WO2006047256A1 (en) | 2004-10-21 | 2006-05-04 | Vertex Pharmaceuticals Incorporated | Triazoles useful as inhibitors of protein kinases |
JP2006516561A (ja) * | 2003-01-17 | 2006-07-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 細胞増殖の阻害剤としての2−アミノピリジン置換ヘテロ環類 |
WO2006093247A1 (ja) | 2005-02-28 | 2006-09-08 | Japan Tobacco Inc. | Syk阻害活性を有する新規なアミノピリジン化合物 |
WO2007070872A1 (en) | 2005-12-15 | 2007-06-21 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1877411B9 (en) * | 2005-05-05 | 2012-08-29 | Ardea Biosciences, Inc. | Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
-
2007
- 2007-12-28 CN CNA2007800488899A patent/CN101611035A/zh active Pending
- 2007-12-28 US US12/521,518 patent/US20100298557A1/en not_active Abandoned
- 2007-12-28 EP EP07860481A patent/EP2123654A4/en not_active Withdrawn
- 2007-12-28 KR KR1020097013434A patent/KR20090103897A/ko not_active Application Discontinuation
- 2007-12-28 CA CA002673965A patent/CA2673965A1/en not_active Abandoned
- 2007-12-28 RU RU2009128982/04A patent/RU2009128982A/ru not_active Application Discontinuation
- 2007-12-28 WO PCT/JP2007/075278 patent/WO2008081928A1/ja active Application Filing
- 2007-12-28 JP JP2008552181A patent/JPWO2008081928A1/ja not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4899194A (ja) | 1972-03-03 | 1973-12-15 | ||
JP2001501216A (ja) * | 1996-10-02 | 2001-01-30 | ノバルティス アクチエンゲゼルシャフト | ピリミジン誘導体およびその製造法 |
WO2000075113A1 (fr) | 1999-06-09 | 2000-12-14 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives carboxamide heterocycliques |
WO2001009134A1 (en) | 1999-07-30 | 2001-02-08 | Novartis Ag | Purine derivatives inhibitors of tyrosine protein kinase syk |
JP2003506375A (ja) * | 1999-07-30 | 2003-02-18 | ノバルティス アクチエンゲゼルシャフト | チロシンタンパク質キナーゼsykのプリン誘導体阻害剤 |
WO2001083485A1 (en) | 2000-04-28 | 2001-11-08 | Bayer Aktiengesellschaft | Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
WO2003057695A1 (en) | 2001-12-21 | 2003-07-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,6 naphthyridines useful as inhibitors of syk kinase |
WO2003063794A2 (en) | 2002-02-01 | 2003-08-07 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and their uses |
JP2004203748A (ja) | 2002-12-24 | 2004-07-22 | Kissei Pharmaceut Co Ltd | 新規なイミダゾ[1,2−c]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途 |
JP2006516561A (ja) * | 2003-01-17 | 2006-07-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 細胞増殖の阻害剤としての2−アミノピリジン置換ヘテロ環類 |
WO2005028480A2 (en) | 2003-09-03 | 2005-03-31 | Neurogen Corporation | 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
WO2005080393A1 (en) * | 2004-02-14 | 2005-09-01 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
WO2005085249A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Fused derivatives of pyrazole |
WO2006047256A1 (en) | 2004-10-21 | 2006-05-04 | Vertex Pharmaceuticals Incorporated | Triazoles useful as inhibitors of protein kinases |
WO2006093247A1 (ja) | 2005-02-28 | 2006-09-08 | Japan Tobacco Inc. | Syk阻害活性を有する新規なアミノピリジン化合物 |
WO2007070872A1 (en) | 2005-12-15 | 2007-06-21 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
Non-Patent Citations (13)
Title |
---|
"DESIGN OF PRODRUGS", 1985, ELSEVIER |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 8, 2003, pages 1415 |
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 13, 2005, pages 4936 |
CANCER RES., vol. 66, no. 11, 1 June 2006 (2006-06-01), pages 5648 - 5655 |
CANCER RES., vol. 67, no. 4, 15 February 2007 (2007-02-15), pages 1580 - 1588 |
J. IMMUNOL., vol. 169, no. 2, 15 July 2002 (2002-07-15), pages 1028 - 1036 |
J. PHARMACOL. EXP. THER., 31 August 2006 (2006-08-31) |
J. PHARMACOL. EXP. THER., vol. 306, no. 3, September 2003 (2003-09-01), pages 1174 - 1181 |
J. PHARMACOL. EXP. THER., vol. 317, no. 2, May 2006 (2006-05-01), pages 571 - 578 |
ONCOGENE, vol. 13, no. 12, 19 December 1996 (1996-12-19), pages 2595 - 2605 |
ONCOGENE, vol. 26, no. 52, 15 November 2007 (2007-11-15), pages 7313 - 7323 |
PROC. NATL. ACAD. SCI. USA., vol. 101, no. 16, 20 April 2004 (2004-04-20), pages 6158 - 6163 |
See also references of EP2123654A4 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8372858B2 (en) | 2006-12-08 | 2013-02-12 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US8957081B2 (en) | 2006-12-08 | 2015-02-17 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
WO2009026107A1 (en) * | 2007-08-17 | 2009-02-26 | Portola Pharmaceuticals, Inc. | Protein kinase inhibitors |
US7705004B2 (en) | 2007-08-17 | 2010-04-27 | Portola Pharmaceuticals, Inc. | Protein kinase inhibitors |
WO2009032703A1 (en) * | 2007-08-28 | 2009-03-12 | Irm Llc | 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
US8273754B2 (en) | 2008-12-30 | 2012-09-25 | Arqule, Inc. | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds |
US8343961B2 (en) | 2009-03-31 | 2013-01-01 | Arqule, Inc. | Substituted heterocyclic compounds |
WO2012057262A1 (ja) * | 2010-10-28 | 2012-05-03 | 日本新薬株式会社 | ピリジン誘導体及び医薬 |
CN103298788A (zh) * | 2010-10-28 | 2013-09-11 | 日本新药株式会社 | 吡啶衍生物及医药 |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
JP2015529232A (ja) * | 2012-09-20 | 2015-10-05 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換ピロロピリミジニルアミノ−ベンゾチアゾロン |
US10913744B2 (en) | 2015-02-13 | 2021-02-09 | Dana-Farber Cancer Institute, Inc. | LRRK2 inhibitors and methods of making and using the same |
Also Published As
Publication number | Publication date |
---|---|
CN101611035A (zh) | 2009-12-23 |
KR20090103897A (ko) | 2009-10-01 |
CA2673965A1 (en) | 2008-07-10 |
EP2123654A1 (en) | 2009-11-25 |
RU2009128982A (ru) | 2011-02-10 |
US20100298557A1 (en) | 2010-11-25 |
JPWO2008081928A1 (ja) | 2010-04-30 |
EP2123654A4 (en) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008081928A1 (ja) | ピラゾロピリミジン化合物 | |
CR20210001A (es) | Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona y su uso en el tratamiento de trastornos dependientes de la proteina con dedos de zinc 2 de la familia ikaros (1kzf2) | |
WO2008076046A8 (en) | Novel 2-amino-5, 5-diaryl-imidazol-4-ones | |
WO2007023382A3 (en) | Pyrimidine amino pyrazole compounds, potent kinase inhibitors | |
WO2006053255A3 (en) | Novel betulin derivatives, preparation thereof and use thereof | |
WO2006039718A3 (en) | Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors | |
TW200734311A (en) | New compounds | |
WO2007009109A3 (en) | Antiviral compounds | |
MX2009012168A (es) | Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta. | |
WO2006020276A3 (en) | Antiviral compounds | |
WO2008142720A3 (en) | Quinazolin-oxime derivatives as hsp90 inhibitors | |
WO2006050161A3 (en) | Therapeutic furopyrimidines and thienopyrimidines | |
WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
WO2005094329A8 (en) | Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor | |
WO2007061737A3 (en) | FUSED BICYCLIC mTOR INHIBITORS | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2008075068A3 (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2009079008A8 (en) | Benzopyrans and analogs as rho kinase inhibitors | |
WO2006039164A3 (en) | Novel cyclosporin analogues and their pharmaceutical uses | |
WO2005117867A3 (en) | Monocyclic heterocycles as kinase inhibitors | |
WO2007076348A3 (en) | Azaindole inhibitors of aurora kinases | |
MX2010007746A (es) | Compuestos de 3h-[1,2,3]triazolo[4,5-d]pirimidina, su uso como inhibidores de diana de rapamicina de mamifero quinasa y fosfatidilinositol quinasa y su sintesis. | |
WO2007011760A3 (en) | Inhibitors of mitotic kinesin | |
WO2008048867A3 (en) | Bicyclic heteroaromatic compounds | |
WO2007069020A3 (en) | N-hydroxyamide derivatives possessing antibacterial activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780048889.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07860481 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008552181 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4151/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2673965 Country of ref document: CA Ref document number: 12521518 Country of ref document: US Ref document number: 1020097013434 Country of ref document: KR Ref document number: 2007860481 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2009128982 Country of ref document: RU Kind code of ref document: A |